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Post-translational modifications of proteins regulate di-
verse cellular functions, with mounting evidence suggest-
ing that hierarchical cross-talk between distinct modifi-
cations may fine-tune cellular responses. For example, in
apoptosis, caspases promote cell death via cleavage of
key structural and enzymatic proteins that in some in-
stances is inhibited by phosphorylation near the scissile
bond. In this study, we systematically investigated how
protein phosphorylation affects susceptibility to caspase
cleavage using an N-terminomic strategy, namely, a modi-
fied terminal amino isotopic labeling of substrates (TAILS)
workflow, to identify proteins for which caspase-catalyzed
cleavage is modulated by phosphatase treatment. We vali-
dated the effects of phosphorylation on three of the identi-
fied proteins and found that Yap1 and Golgin-160 exhibit
decreased cleavage when phosphorylated, whereas cleav-
age of MST3 was promoted by phosphorylation. Further-
more, using synthetic peptides we systematically examined
the influence of phosphoserine throughout the entirety of
caspase-3, -7, and -8 recognition motifs and observed a
general inhibitory effect of phosphorylation even at resi-
dues considered outside the classical consensus motif.
Overall, our work demonstrates a role for phosphorylation
in controlling caspase-mediated cleavage and shows that
N-terminomic strategies can be tailored to study cross-talk
between phosphorylation and proteolysis. Molecular &
Cellular Proteomics 13: 10.1074/mcp.M113.037374, 1184–
1197, 2014.
Apoptosis is a cell death program integral to various biolog-
ical processes such as tissue homeostasis and development
(1). The ability of cancer cells to evade apoptosis is considered a
driving feature that imparts a selective cellular advantage allowing
cells to persist inappropriately (2). A major component of apopto-
tic evasion in cancer arises from the misregulation of two enzyme
classes, protein kinases and caspases. Kinases transfer the
-phosphate from ATP to proteins to alter substrate function, and
caspases act as executioners of the apoptotic program by facili-
tating the demolition of cellular constituents by cleaving key struc-
tural and enzymatic proteins (3, 4). Attenuation of caspase activity
arising through kinase-mediated post-translational modifications
or genetic mutations or deletions can contribute to malignant
phenotypes by blocking apoptotic progression (5, 6).
Interestingly, numerous examples have implicated cross-talk
between caspases and kinases as a major apoptotic regulatory
mechanism, and anecdotal examples have been identified in
which phosphorylation at P4, P2, and P1 (see Fig. 1A for
cleavage site nomenclature) has been shown to block cleavage
and affect cellular phenotypes (6–12). Accordingly, phosphory-
lation-dependent regulation of caspase-mediated cleavage has
been hypothesized as a global regulator of apoptotic progres-
sion, especially in the context of cancer, where hyperactive,
oncogenic kinases may act to increase phosphosite occupancy
within caspase cleavage motifs (7). Indeed, we previously tested
this hypothesis using predictive peptide match programs and
identified CK2 phosphorylation sites on caspase-3 that regu-
lated its activation by caspase-8 and -9 (13).
To build on our predictive strategy, we devised an unbi-
ased, proteomic methodology to identify novel proteins for
which phosphorylation regulates cleavage via caspases. We
measured the caspase degradome in the context of a native
phosphoproteome and compared it to the caspase degra-
dome generated from lysates formerly dephosphorylated with
 bacteriophage phosphatase. To identify these events, we
utilized the N-terminomic workflow TAILS1 (terminal amino
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isotopic labeling of substrates) (14). Comparative analysis of
the caspase degradomes from phosphorylated and dephos-
phorylated lysates revealed Yap1 and Golgin-160 as caspase
substrates negatively regulated by phosphorylation.
Surprisingly, we also identified a number of caspase sub-
strates for which cleavage is promoted by phosphorylation,
and during the course of our study, Dix et al. (15) demon-
strated that phosphorylation at P3 can promote the cleavage
of caspase peptide substrates. Our proteomic screen high-
lighted MST3 as a caspase substrate positively regulated by
phosphorylation; however, in contrast to results obtained for
MST3 protein in lysates, phosphorylation exerted a negative
influence on the cleavage of an MST3 peptide, as was the
case for other peptides modeled after Yap1 and Golgin-160.
Collectively, these data suggest that although inhibitory ef-
fects of phosphorylation can arise through phosphorylation of
residues proximal to the cleavage site, the positive effect of
phosphorylation may stem from determinants other than
those near the scissile bond. Subsequently, to test the effect
of phosphorylation throughout the entirety of the caspase
motif, we systematically walked phosphoserine through the
length of model caspase-3, -7, and -8 substrate peptides and
found that phosphorylation was generally inhibitory to
caspase cleavage. Again, these observations suggest that
positive effects of phosphorylation on the caspase cleavage
of proteins observed in lysates likely arise through modulated
ternary protein structure. Overall, our studies demonstrate
that N-terminomics approaches can be tailored to identify
novel, hierarchical events controlling the cleavage of caspase
substrates.
EXPERIMENTAL PROCEDURES
Caspase Degradome Preparation—HeLa cells were cultured in Dul-
becco’s modified Eagle’s medium containing 10% fetal bovine se-
rum, penicillin (100 U/ml), and streptomycin (100 mg/ml). Cells were
treated for 45 min with 1 M okadaic acid (Bioshop Canada Inc.,
Burlington, Ontario, Canada) and then lysed in caspase assay buffer
(0.1% CHAPS, 20 mM PIPES (pH 7.4), 100 mM NaCl) and protease
and phosphatase inhibitors (leupeptin (10 g/ml), 0.1 mM phenyl-
methylsulfonyl fluoride (PMSF), pepstatin A (10 g/ml), aprotinin (5
g/ml), 50 mM NaF, 1 M microcystin, and 1 mM sodium orthovana-
date). Cells were lysed by sonication with two pulses of 5 s each, and
the samples were subsequently cleared by ultracentrifugation at
13,000  g if being used for Western blot analysis or 140,000  g if
being used for proteomic analysis. Lysates were then exchanged into
100 mM HEPES (pH 7.0) 3 using 3 K cut-off buffer exchange filters
(Amicon, Billerica, MA) to remove phosphatase inhibitors prior to 
phosphatase treatment and small-molecule primary amines to permit
complete dimethyl labeling of primary amines on proteins. The protein
concentration was determined by using the Bradford assay. After
buffer exchange, the sample was split in two, diluted in 10 phos-
phatase buffer (NEB) and 5 caspase buffer (see above for the 1
recipe), and then treated with or without  phosphatase (10 U NEB 
phosphatase per microgram of lysate) for 1 h at 37 °C. Next, lysates
were treated with 50, 500, or 5000 nM of caspase-3 and caspase-7 for
1 h at 37 °C, and the reaction was terminated by the addition of 6 M
irreversible caspase inhibitor z-VAD-fmk (Sigma). Caspase concen-
trations of 50 and 500 nM were used in TAILS experiments. For
validation studies employing Western blot, we also included a higher
caspase concentration (5000 nM) to ensure that caspase concentra-
tions were not limiting and to stringently assess the protective effect
of phosphorylation. Finally, samples previously left phosphorylated
were treated with  phosphatase as described above, and either
samples were further processed using TAILS for proteomic analysis
or 2 Laemmli buffer was added for Western blotting.
Sample Preparation Using TAILS—TAILS was performed largely as
described previously (16). Briefly, caspase degradomes were diluted
1:1 in 8 M guanidine hydrochloride. Cysteine residues were reduced
by 5 mM DTT, incubated at 65 °C for 1 h, and then alkylated by
iodoacetamide treatment for 2 h at room temperature in the dark.
After excess iodoacetamide had been quenched with DTT, the pH
was adjusted to 6.5 using 0.5 N HCl to prepare for the dimethyl
labeling of primary amines. Primary amino groups were dimethylated
by the addition of 20 mM NaBH3CN and 40 mM
12CH2-formaldehyde
(light) (Sigma) or 13CD2-formaldehyde (heavy) by reaction at 37 °C
overnight, followed by quenching with 100 mM Tris (pH 6.8) for 4 h.
Samples were mixed at this point, and proteins were precipitated with
cold methanol and acetone (8:1), washed three times with methanol
to remove excess label and amines, resuspended in 8 M guanidine
hydrochloride, and diluted 8-fold in 1 M HEPES (pH 8.0). Trypsin
(Promega, Madison, WI) was added (1:100 trypsin:lysate (w/w)) and
samples were incubated overnight at 37 °C, with incubation followed
by a fresh trypsin addition (1:200) for another 4 h. Finally, internal
tryptic peptides were reacted with HPG-ALDII polymer (Flintbox,
Pittsburg, PA) to negatively select for protein N termini and caspase-
generated dimethylated neo-N termini. Here, 2 mg of polymer and 20
mM NaBH3CN were added to 1 mg of lysate, the pH was adjusted to
6.5 with HCl, and the reaction incubated at 37 °C overnight. After
quenching with 100 mM Tris (pH 6.8), negative selection of N termini
was performed by filtering the polymer (80 kDa) with a 10-kDa-
cutoff Microcon spin-filter as per the manufacturer’s instructions. We
cleaned up the N terminome containing flow-through on a C18 light
Waters Sep-Pak by acidifying the sample in 0.1% formic acid, apply-
ing it to the column, washing with 0.1% formic acid, and eluting in
80% acetonitrile/0.5% formic acid. Samples were then vacuum cen-
trifuged and stored at 20 °C until mass spectrometry analysis.
Peptide Identification Using Mass Spectrometry—The peptides
were resuspended in 2% acetonitrile/0.1% formic acid/97.9% water
and loaded onto a 2 cm long  360 m outer diameter  100 m
inner diameter microcapillary fused silica precolumn packed with
Magic 5-m C18AQ resin (Michrom Biosciences, Inc., Auburn, CA).
After sample loading, the precolumn was washed with 95% solvent A
(0.1% formic acid in water)/5% solvent B (0.1% formic acid in ace-
tonitrile) for 20 min at a flow rate of 2 l/min. The precolumn was then
connected to a 360 m outer diameter  75 m inner diameter
analytical column packed with 14 cm of 5-m C18 resin constructed
with an integrated electrospray emitter tip. The peptides were eluted
at a flow rate of 250 nL/min by increasing the percentage of solvent
B to 40% with a Nano-Acquity HPLC solvent delivery system (Waters
Corp., Mississauga, Ontario, Canada). The LC system was directly
connected through an electrospray ionization source interfaced to an
LTQ Orbitrap Velos ion trap mass spectrometer (Thermo Electron
Corp., Waltham, MA). The mass spectrometer was controlled by
Xcalibur software (Thermo, v. 2.1.0.1140) and operated in the
data-dependent mode in which the initial MS scan recorded
the mass-to-charge ratios (m/z) of ions over the range of 400–2000.
The 10 most abundant ions were automatically selected for subse-
quent collision-activated dissociation in ion trap mode. Each sample
was run in duplicate. Raw files were searched and quantified using
Maxquant (17) version 1.2.2.5 using the UniProt database (84,909
sequences, November 20, 2012). Searches included cysteine resi-
dues as a fixed modification of 57.0215 Da, oxidized methionine
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residues as a variable modification of 15.9949 Da, and deamidated
asparagine and glutamine residues as a variable modification of
0.9840. Light and heavy dimethylation of peptide amino termini and
lysine residues were set as variable modifications of 28.0313 Da
and 34.0631 Da, respectively. Peptides were queried using Asp-C
(caspase cleaves only after Asp residues) and Arg-C (trypsin cannot
cut after dimethylated lysine) cleavage constraints with a maximum of
two missed cleavage sites. The mass tolerances were 6 ppm for
parent masses and 0.6 Da for fragment masses. The peptide false
discovery rate was set at 0.01. Only peptides identified in at least two
runs were used, and peak ratios were averaged by taking the geo-
metric mean of the heavy:light ratio. Technical duplicates of three
experiments were performed. Protein N-terminal peptide and P1 Asp
peptide ratios were normalized by dividing all ratios by the average
ratio of the protein N-terminal peptides. The weblogo of P1 Asp
peptides was determined as previously described (18).
Western Blotting—Samples were separated on SDS-PAGE gels
and transferred to PVDF membrane using standard procedures.
Membranes were blocked with 5% BSA/TBS–Tween 20 and probed
overnight with primary antibodies in 1% BSA/TBS–Tween 20. PKC,
MST1, MST3, Yap1, and Golgin-160 antibodies were all purchased
from Abcam, Toronto, Ontario, Canada. Presenilin-1 antibodies were
from Novus Biologicals, Littleton, CO, phospho-Histone H2B was from
Cellular Signaling Technology, Danvers, MA, and phospho-EEF1D and
phospho-EEF1B were made as previously described (19). Secondary
antibodies conjugated with fluorogenic 680 or 800 dyes were pur-
chased from Li-COR Biosciences, and blots were imaged using a
Li-COR Odyssey imager, Lincoln, NE.
Apoptotic Induction of HeLa Cells—Cells were treated with 1 M
staurosporine (LC Laboratories, Woburn, MA) and 500 nM okadaic
(Bioshop, Burlington, Ontario Canada), with both drugs or with a
carrier (dimethyl sulfoxide) control for 3 h. Cells were collected and
lysed in Nonidet P-40 alternative lysis buffer (1% Nonidet P-40 alter-
native, 150 mM NaCl, 50 mM Tris (pH 7.5), leupeptin (10 g/ml), 0.1
mM PMSF, pepstatin A (10 g/ml), aprotinin (5 g/ml), and 1 M
zVAD-fmk (Sigma)). After brief sonication and clearance of insoluble
material by centrifugation (13,000  g for 15 min at 4 °C), the protein
concentration was assessed using a bicinchoninic acid assay
(Thermo Scientific). Lysates were dephosphorylated as described
above to reduce the differential migration of phosphorylated proteins,
thereby simplifying Western blot analysis. Approximately 20 g of
lysates were then separated on SDS-PAGE gels and blotted as de-
scribed above.
Peptides—PARP1 and caspase-3 peptides were synthesized as
previously described (13) via standard Fmoc-based peptide chemis-
try with an Automated Multiple Peptide Synthesizer (Intavis, Cologne,
Germany). Fmoc-Lys(dinitrophenol)-OH (Bachem, Torrance, CA) was
attached to the C terminus of each peptide, and peptides were
capped with Fmoc-Trp-OH and biotin at the N terminus. Phosphor-
ylated peptides were generated with Fmoc-Ser [Ser[PO(OBzl)-
OH]-OH (AnaSpec, Fremont, CA). Peptides were resuspended in 250
mM HEPES (pH 7.5) and the pH was adjusted to 7.5 with NaOH. The
peptide concentration was determined by OD 355, and identity was
verified via MALDI-TOF. Peptide series for MST3, Yap1, and Golgin-
160 were synthesized by ChinaPeptides, Shanghai, China. Quality
control documents for HPLC chromatography and mass spectrome-
try were provided as verification of purity (95%) and peptide iden-
tity, respectively.
Caspase Assays—Recombinant caspase-3 (Addgene plasmid
number 11821 (20)), caspase-7 (Addgene plasmid number 11825
(20)), and caspase-8 (Addgene plasmid number 11827 (20)) were
purified and their activity was assessed via active site titration as
described previously (21). Peptides used as caspase substrates were
synthesized with a FRET pair of tryptophan and lysine-DNP at either
terminus. Quenching of tryptophan fluorescence by DNP is relieved
by caspase cleavage, allowing one to determine caspase cleavage by
monitoring tryptophan fluorescence at 355 nm. Caspase-3 assays
were performed with 200 nM (PARP1), 800 nM (Yap1, Golgin-160), or
1.2 M (MST3) caspase and 100 M peptide at 37 °C in 20 mM PIPES
(pH 7.4), 100 mM NaCl, 5% sucrose, 0.1% CHAPS (w/v), and 5 mM
DTT for 15 min. Caspase-7 assays were performed in the same buffer,
but with 200 nM (Golgin-160), 500 nM (Golgin-160), 600 nM (PARP1),
1 M (MST3), or 2.5 M (Yap1) caspase. Caspase-8 reactions were
performed with 100 nM caspase-8 in 1 M sodium citrate and 35 mM
NaH2PO4/Na2HPO4 (pH 7.4) at 37 °C for 5 min. Dephosphorylation of
peptides prior to caspase treatment was achieved using an excess of
recombinant bacteriophage  phosphatase in Protein MetalloPhos-
phatase buffer (NEB) with 1 mM MnCl2 for 1 h at 37 °C. Caspase
reactions were quenched by the addition of the irreversible caspase
inhibitor z-VAD-fmk (Sigma), diluted 1 in 4 and emission read at 355
nm after excitation at 280 nm. Fluorescence was measured on a
Horiba fluorolog-3 spectrofluorometer (supplemental Fig. S4A) or on
a SpectraMax M5 fluorescence plate reader. Reactions were per-
formed in quadruplicate, and analysis of variance and Tukey’s test
were used to compare the mean fluorescence of phosphorylated
peptides with that of their unphosphorylated or phosphatase-treated
counterparts.
RESULTS
Unbiased Proteomic Evaluation of Phosphorylation-de-
pendent Regulation of Caspase-mediated Cleavage—In an
effort to characterize the interplay between phosphorylation
and caspase-mediated degradation, we applied a proteomics
approach to identify phosphorylation-regulated caspase sub-
strates. In our workflow, lysates from HeLa cells (treated with
okadaic acid to preserve cellular phosphorylation) were
treated with or without  phosphatase followed by recombi-
nant caspase (Fig. 1B). In order to maximize the number of
substrates identified while minimizing the number of mass
spectrometry runs, we added a mixture of two executioner
caspases, caspase-3 and caspase-7, that are responsible for
the majority of cleavage events in apoptosis and have almost
identical consensus motifs (22, 23). Next, we utilized TAILS as
a means for enriching the proteome for caspase substrates
(14). Here, caspase-degraded proteomes are isotopically la-
beled at N-terminal residues and lysine residues with heavy
(34) or light (28) formaldehyde. Trypsin digestion reveals
internal peptide N termini whose amine groups are reactive
against an aldehyde-coupled, high-molecular-weight resin,
whereas the amine groups of protein N termini and caspase-
generated N termini remain inert as a result of blockage by
dimethylation. Filtering the lysate through a 10K cut-off mem-
brane removes the reacted resin/internal tryptic peptide spe-
cies, allowing for enrichment of the N-terminome in the flow-
through. Performing LC-MS/MS analysis on an LTQ-Orbitrap
identifies N termini, and from the differential dimethyl labeling,
ion intensities from MS are used to produce a quantitative
comparison between caspase degradomes from phosphory-
lated and dephosphorylated lysates. Importantly, after diges-
tion with caspases, the phosphorylated lysate was treated
with phosphatase. This allowed a direct quantitative compar-
ison between caspase substrates that might have a phos-
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FIG. 1. Workflow for the global, unbiased analysis of the integration of phosphorylation and caspase-mediated degradation. A,
illustration of the cleavage site nomenclature for proteases. Caspases cleave the scissile bond between a P1 aspartic acid and the P1 residue.
B, HeLa cell lysates were treated with or without  phosphatase and subjected to caspase treatment followed by dephosphorylation of the
sample previously left phosphorylated. Primary amines on protein N termini and lysine residues were dimethylated using heavy (34, open circles)
or light (28, black circles) formaldehyde. Samples were pooled and trypsinized, which exposed an amine on the N terminus of the internal tryptic
peptide. These peptides are captured through reaction with an 80-kDa aldehyde-substituted polymer. Importantly, native protein N termini and
neo-N termini generated by caspase cleavage are resistant to reaction with the polymer because their reactive amines have been blocked by
dimethylation. Enrichment of the N-terminome then occurs via negative selection when the reacted polymer is filtered away using a 10-kDa cut-off
spin column. LC-MS/MS analysis of isotopically dimethylated peptides then allows comparative analysis between caspase degradomes of
phosphorylated and dephosphorylated lysates. Caspase substrates will be inferred through identification of those peptides with a P1 aspartic acid.
In the event that there is no difference in caspase substrate proteolysis between phosphorylated and dephosphorylated samples, a peptide ratio
of 1:1 will be observed in MS1 [1]. Of interest are those peptide pairs that deviate from a 1:1 ratio [2].
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phorylation site that, if occupied, would alter retention time or
mass and undermine comparative analyses.
Before analyzing proteomic samples via mass spectrome-
try, we first tested for the efficient dephosphorylation of cell
extracts and the presence of cleaved caspase substrates.
Samples were analyzed at different points throughout the
workflow (supplemental Fig. S1) for EEF1D and EEF1B phos-
phorylation and caspase cleavage of the previously identified
substrate MST1 (24).  phosphatase treatment resulted in
efficient dephosphorylation of phospho-EEF1D and phospho-
EEF1B, two abundant phosphorylated proteins with near stoi-
chiometric phosphorylation (supplemental Fig. S1A, lanes 1
and 2) (19). Next these samples were treated with 50 or 500
nM caspase-3 and caspase-7, which resulted in a dose-de-
pendent decrease in full-length MST1 (supplemental Fig. S1A,
lanes 3–6). Finally, the addition of  phosphatase to previ-
ously phosphorylated lysate abolished phospho-EEF1D and
phospho-EEF1B antibody reactivity (supplemental Fig. S1A,
lanes 3 and 5). Further validating the efficiency of our enzyme
treatments, we found that lysate phosphatase assays abol-
ished the reactivity of phospho-H2B antibodies when using
extracts generated from nocodazole arrested cells and in-
creased migration for total Presenilin-1 levels, again indicative
of complete dephosphorylation (supplemental Fig. S1B). We
also tested PKC, another known caspase substrate (25), for
cleavage in lysates treated with a gradient of caspase-3 and
caspase-7 concentrations (supplemental Fig. S1C). Proteoly-
sis was again dose dependent and occurred with levels of
caspases used previously in lysate cleavage assays (26).
Confident in our enzyme treatments of cell lysates, we
generated TAILS samples from extracts treated with or with-
out  phosphatase and 50 or 500 nM caspase-3 and
caspase-7. We identified and quantified 57 peptides with a P1
Asp, suggestive of caspase cleavage (see supplemental Table
S1 and supplemental Fig. S2 for MS2 spectra). Only peptides
identified in at least two replicates (either biological or tech-
nical) were considered hits. WebLogo analysis (18) of P1 Asp
peptides generated a motif consistent with the consensus
previously ascribed to caspase-3 and caspase-7 (DEVD, Fig.
2A) (23). Importantly, N-terminomic analysis of untreated Jur-
kat cells performed by Mahrus et al. (27) revealed that less
than 5% of protein N termini contain a P1 Asp, reinforcing the
conclusion that the majority of the P1 Asp peptides we iden-
tified were caspase substrates. As well, when our P1 Asp
dataset was compared with the DegraBase repository of apo-
ptotic N termini, we found that there was a 42% overlap,
further substantiating the finding of bona fide caspase sub-
strates in our data (supplemental Table S1) (28). Analysis of
the log2 values of cleavage ratios comparing phosphatase
treatment to control revealed a shift toward more cleavage in
the control samples, perhaps indicating a general positive
influence of phosphorylation on caspase cleavage at the pro-
teome level (Figs. 2B and 2C). This skew was likely not due to
labeling or sample bias, as P1 Asp quantitative data were
normalized to the quantified protein N termini isolated using
TAILS (see supplemental Table S2 and supplemental Fig. S3
for MS2 spectra), which should not change as a result of
caspase treatment. In Fig. 2, we report the Gene Ontology of
all identified caspase substrates (Fig. 2D) and of those posi-
tively regulated by phosphorylation (Fig. 2E); we found that a
number of biological processes were represented. These ob-
servations are consistent with the broad effects of caspase
during the progression of apoptosis.
To validate the quantitative data returned from TAILS anal-
ysis, we repeated lysate dephosphorylation/caspase experi-
ments and probed for candidates using Western blotting. We
focused on substrates with consistent changes in cleavage
across multiple replicates and on those either previously iden-
tified as caspase substrates or whose cleavage site matched
the caspase-3 and caspase-7 consensus motif. Using these
criteria, we selected three candidates for validation: MST3,
Yap1, and Golgin-160 (Fig. 3A and bars highlighted in red in
Fig. 2C). MS/MS spectra for the identified P1 Asp peptides are
shown in Figs. 3B, 3C, and 3D. The MST3 cleavage site
(AETD325) was reported previously (29), and we found that it
was preferentially cleaved in phosphorylated lysates. Western
blotting analysis revealed a modest but consistent change in
the amount of full-length MST3 that differed between 
phosphatase–treated and untreated lysates (Fig. 3E, upper
panel). In contrast, we found that Yap1 was preferentially
cleaved when lysates were dephosphorylated. Though cleav-
age of Yap1 at DEMD424 was not a previously known caspase
site, the primary amino acid determinants do align with the
caspase-3 and caspase-7 consensus motif, increasing our
confidence that the site is a true positive. Furthermore, treat-
ing lysates with caspase-3 and caspase-7 resulted in a dose-
dependent decrease of full-length Yap1, as well as the gen-
eration of smaller anti-Yap1 reactive bands (Fig. 3E, middle
panel). Full-length Yap1 was also slightly more resistant to
caspase cleavage when lysates were treated with  phospha-
tase. Also, two degradation products persisted in the phos-
phorylated samples, which is also consistent with a protective
role for phosphorylation (Fig. 3E, arrow and arrowhead).
Lastly, we found that Golgin-160 (referred to as GOLGA3 in
supplemental Table S1) was also cleaved less in phosphory-
lated lysates at SEVD311, a site previously identified as tar-
geted by caspase-3 and caspase-7 in vitro and in response to
diverse apoptotic stimuli (30, 31). Repeating TAILS experi-
ments and measuring cleavage by Western blotting, we ob-
tained results that were again consistent with the data re-
turned from TAILS (Fig. 3E, lower panel). Here, in the
phosphatase-treated lysates, a more rapid conversion to the
fully cleaved form was observed. In contrast, an intermediate,
slower migrating cleavage fragment remained even at the
highest dose of caspase-3 and caspase-7 (5 M) in the phos-
phorylated lysates. Caspase-3 and caspase-7 can also cleave
Golgin-160 at D59 and D139 (30), and so our blots were con-
sistent with the model in which intermediate cleavage frag-
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ments of Golgin-160 have been processed at these other
residues but phosphorylation blocked proteolysis at SEVD311.
Ultimately, these data highlight novel mechanisms regulating
the susceptibility of MST3, Yap1, and Golgin-160 to caspase
cleavage.
Considering the notion that misregulation of oncogenic pro-
tein kinases can impede the progression of apoptosis (6, 7),
we were interested in understanding the physiological rele-
vance of phosphorylation events that block caspase substrate
cleavage. To test how Golgin-160 and Yap1 phosphorylation
affects their cleavage in cells, we induced HeLa cells to un-
dergo apoptosis in the presence or absence of the phospha-
tase inhibitor okadaic acid. Apoptotic induction resulted in
considerable PARP1 cleavage, a bona fide marker of
caspase-3, -6, and -7 activity (32), in cells treated with stau-
rosporine alone and in combination with okadaic acid (Fig.
3F). Interestingly, combination treatments reduced full-length
Yap1 processing and almost completely blocked Golgin-160
cleavage. Similarly, the appearance of degradation bands for
these proteins was reduced when apoptotic cells were treated
with okadaic acid. We cannot rule out that indirect effects of
okadaic acid treatment modulate cleavage of these sub-
strates, but the patterns are consistent with that seen in vitro
and support a role for either active substrate dephosphory-
lation upon apoptotic induction or okadaic-acid-induced in-
creases in the stoichiometry of phosphorylation.
FIG. 2. Summary of the peptides identified via TAILS. A, a WebLogo analysis (18) of the 57 peptides with P1 aspartic acid that were
identified via TAILS. B, a log2 histogram of the quantified P1 Asp peptides was plotted to visualize the distribution of the effect of
phosphorylation on caspase cleavage. The number of peptides in each group is indicated. C, a log2 mountain plot of the quantified P1 Asp
peptides. MST3, Yap1, and Golgin-160 are highlighted in red. The peptides and their relative abundance are also presented in supplemental
Table S1. D, E, Gene Ontology (GO) analysis was performed for all P1 Asp peptides (D) or those positively regulated by phosphorylation (i.e.
substrates with more pronounced regulation than MST3; see red bar with log2  0 in C) (E) using PANTHER (45, 46).
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As a logical extension of the TAILS analysis, we were
interested in systematically testing the effects of phosphor-
ylation on cleavage using synthetic peptides modeled after
caspase substrates identified by TAILS. For these studies,
we generated a series of peptides to test whether phosphor-
ylation within the caspase consensus motif was responsible
for the observed differences in cleavage. Synthesized pep-
tides were designed with the FRET pair of tryptophan and
lysine-DNP at either terminus (supplemental Table S3).
When the peptide is intact, emission by tryptophan at 355
nm after excitation at 280 nm is quenched by DNP, which
absorbs at 355 nm. Following substrate cleavage, the re-
lease of tryptophan in close proximity to DNP abolishes
quenching and permits monitoring of reaction rates by
measuring tryptophan fluorescence at 355 nm. Indeed, re-
actions with control peptides that model the PARP1 cleav-
age site, which has previously been used as a peptide
substrate for caspase-3 and caspase-7 (8, 13), maintained
linearity through 15 min of reaction time and was not
cleaved when the P1 residue was substituted to Ala (sup-
plemental Fig. S4A). Similar results were seen for the
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FIG. 3. TAILS analysis revealed MST3, Golgin-160, and Yap1 as validated candidates in which cleavage is regulated by phos-
phorylation. A, caspase recognition motif in MST3, Yap1, and Golgin-160. MS/MS analysis of MST3 (B), Yap1 (C), and Golgin-160 (D). E, HeLa
lysates were treated identically to those samples prepared for N-terminomic analysis (as described in “Experimental Procedures”), except
when they were utilized for Western blotting with antibodies directed against MST3, Yap1, or Golgin-160 as indicated. Caspase-3 and
caspase-7 were used at concentrations of 0, 50, 500, and 5000 nM. The asterisk denotes a nonspecific band, and the arrow and arrowhead
bands were differentially regulated by lysate dephosphorylation. F, HeLa cells were treated for 3 h with 1 M staurosporine and/or 500 nM
okadaic acid prior to lysis. Lysates were analyzed using immunoblots with the indicated antibodies. PARP1 cleavage was used as a control
for caspase activation. The asterisk denotes a nonspecific band.
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tides (supplemental Fig. S4B) and nonphosphorylated pep-
tides modeled after MST3, Golgin-160, and Yap1 (data not
shown), demonstrating the utility of this assay for monitor-
ing caspase activity.
Synthetic peptides modeled after Yap1, Golgin-160, or
MST3 were shown to be cleaved by either caspase-3 or
caspase-7 (Fig. 4). In the case of Yap1 (Fig. 4A), phosphory-
lation of P1 completely blocked cleavage. Interestingly, the
phospho-P4 peptide corresponding to Yap1 was also
cleaved less efficiently than the nonphosphorylated parent
peptide. Notably, this position is located a considerable dis-
tance from P4–P1—the motif primarily responsible for direct-
ing caspase cleavage (23, 33)—and had not previously been
shown to affect caspase cleavage. Phosphatase treatment
confirmed the effects of phosphorylation, as dephosphory-
lation restored cleavage of both of the Yap1 phosphopeptides
to the levels seen with nonphosphorylated parent peptide.
Phosphorylation at P4, and to a lesser extent at P4, also re-
duced cleavage of the Golgin-160 peptides (Fig. 4B). Again,
phosphatase treatment of phosphopeptides restored caspase
cleavage to the levels seen with the nonphosphorylated parent
peptide. Results with Yap1 and Golgin-160 peptides corre-
sponded well with results from TAILS experiments: dephos-
phorylation was shown to promote cleavage of both of these
proteins, revealing a negative effect of phosphorylation on
cleavage. The cleavage patterns exhibited by this series of
peptides were shared between caspase-3 and caspase-7, a
result that is supported by previous findings that note almost
identical consensus motifs for these two caspases (23).
We were also interested in examining peptides modeled
after proteins such as MST3 for which phosphorylation could
have a positive effect on cleavage. In contrast to results seen
with intact MST3 in lysates, where phosphorylation appeared
to promote cleavage, phosphorylation at P2 completely abol-
ished cleavage, and phosphorylation of P4 also displayed an
inhibitory effect. These data are discordant with the TAILS
analysis, suggesting that these residues either (i) were not
phosphorylated/dephosphorylated on full-length MST3 in our
lysate assays or (ii) have context specific effects on cleavage
that depend on the structure of the protein that are not rep-
resented in the primary sequence. To further explore the
possibility that phosphorylation could promote cleavage, we
also generated peptides modeled after NFI and ANX2, the two
proteins that exhibited the most positive effects of phosphor-
FIG. 4. Caspase activities toward synthetic peptides modeled after substrates identified via TAILS. Synthetic peptides or phospho-
peptides modeled after Yap1 (A), Golgin-160 (B), or MST3 (C) were treated with or without  phosphatase as indicated prior to incubation with
caspase-3 or caspase-7. Fluorescence of an internally quenched tryptophan residue at 355 nm after excitation at 280 nm was measured to
assess caspase cleavage of peptide substrates. Error bars represent the standard deviation of four reactions. Means for the caspase activities
with phosphorylated peptides and their unphosphorylated counterparts were compared using analysis of variance and Tukey’s test. Control
versus phosphatase-treated pairs for phosphopeptides all had p values  0.0001.
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ylation in lysates. We were unable to perform assays with the
NFI peptide because of the low solubility of both nonphos-
phorylated and phosphorylated versions of these peptides.
However, in the case of ANX2, the nonphosphorylated pep-
tide had a low rate of cleavage that was not enhanced with the
phosphorylated version of the peptide (data not shown).
These data are consistent with the effects of phosphorylation
residing in structural or distal, rather than proximal, primary
sequence determinants.
Systematic Characterization of the Effect of Phosphoserine
on Caspase Cleavage—By testing peptide models of candi-
date proteins identified in the TAILS analysis, we found that
phosphorylation at four positions within P4–P4 inhibited pro-
teolysis. Interestingly, these data are somewhat at odds with
our finding that phosphorylation appeared more likely to pos-
itively regulate the cleavage of proteins in lysates, and they
suggest that in these instances phosphorylation events out-
side the caspase motif might be controlling proteolysis. The
potential complexity of distal, structurally guided regulations
coupled with the anecdotal examples here and elsewhere (8,
13) of caspase motif phosphorylation regulating proteolysis
prompted us to systematically and rigorously define the de-
terminant properties of phosphorylated residues throughout
the caspase motif. To address this question, we designed
three phospho-scanning model peptide series in which phos-
phoserine was positioned from P5–P4 within the caspase-
3/-7 model sequence and from P4–P3 for the caspase-8
model sequence (supplemental Table S3). A broader series
was used for caspase-3 and -7 because of the observation
that primary amino acid specificity can extend beyond
the canonical P4–P1 residues for these caspases (34).
Caspase-3 and -7 substrate series were modeled after Gol-
gin-160 and the often used PARP1 sequence (8, 13), and a
series based on the caspase-3 sequence served as a peptide
substrate for the initiator caspase-8.
The phospho- and non-phosphopeptides for the Golgin-
160 and PARP1 series produced essentially identical patterns
for caspase-3 and caspase-7; this is perhaps not surprising
given their extensive sequence and consensus motif similarity
(Figs. 5A and 5B) (23, 35). Analyzing the unphosphorylated
series revealed that the relative effect of serine throughout
P5–P4 was consistent with the literature. For instance, sub-
stituting serine for Asp at P4 decreased substrate conversion
by a factor of 10 (data not shown) relative to the PARP1
model, but it became a measurable substrate at higher en-
zyme concentrations (see asterisk in Fig. 5B). Stennicke et al.
(33) also observed a large decrease in Kcat/Km when substi-
tuting aspartic acid at P4 to serine for caspase-3 and -7
peptide substrates. Similarly, substituting serine for glutamic
acid at P3 decreased catalysis of Golgin-160 and PARP1,
which is consistent with previous work (23). Whereas Sten-
nicke et al. (33) reported no effect of serine at P1, we ob-
served a modest decrease in cleavage with serine at this
position with both Golgin-160- and PARP1-derived peptides.
Finally, we detected a reduction of cleavage when serine
occupied P2 in the Golgin-160 peptide series, using either
caspase, which is consistent with previous reports (23). Col-
lectively, the analysis of serine throughout the consensus
motif for caspase-3 and -7 model peptides demonstrated a
strong correlation with the literature and validated our exper-
imental system.
Golgin-160 and PARP1 phosphoserine peptides revealed
an overall inhibitory effect of phosphorylation on proteolysis
(Figs. 5A and 5B). Expectedly, phosphorylation at P2 (13) and
P1 (8) completely abolished cleavage. Phosphorylation at P3,
which has previously been reported to have no effect on
cleavage (8) as well as the capacity to promote cleavage in
some instances (15), did not overtly alter proteolysis relative
to the nonphosphorylated controls in our experiments. Our
peptide series also investigated phosphorylated positions not
previously assessed for their capacity to alter caspase cleav-
age. In this regard, phosphorylated P2 almost completely
abolished proteolysis. Phosphorylation at P3 and P4 had a
modest inhibitory effect, as did phosphorylated P5, though
the latter observation held only for the PARP1 model pep-
tides. Overall, phosphorylated serine within four amino acids
of the scissile bond decreased caspase-mediated cleavage,
though phosphorylated P3 and P5 showed modest, model-
specific effects.
We also extended our systematic analysis of the effect of
caspase-motif phosphorylation on proteolysis to the initiator
caspase-8. The effect of caspase-8 cleavage site phosphor-
ylation showed trends similar to those of caspase-3 and
caspase-7. Proteolysis was inhibited by phosphoserine at P4,
P2, P1, and P2, whereas P3 was unaffected by phosphory-
lation (Fig. 6). To some degree, this latter result is in contrast
to a recent report by Dix et al. (15), who found that phos-
pho-P3 was exclusively a positive determinant for caspase-8
cleavage, but our findings are at least consistent in that inhi-
bition was not observed when peptide substrates contained
phosphorylated P3. Also, relative to caspase-3 and
caspase-7, the effect of prime side phosphorylation on cleav-
age is less dramatic, as no significant difference between
serine-P3 and phosphoserine-P3 was observed. Taken to-
gether with our N-terminomic data, the generally negative
determinant properties of phosphoserine suggest that the
phosphorylation-dependent promotion of proteolysis is con-
trolled by factors outside of the primary amino acid sequence
of the canonical caspase motif.
DISCUSSION
The convergence of caspase and kinase signaling has re-
cently been described as a major mechanism in the regulation
of apoptosis (6, 7). We utilized a TAILS N-terminomic strategy
to monitor alterations in the caspase degradome of HeLa
extracts by comparing the native phosphoproteome to lysates
formerly dephosphorylated with  phosphatase. Through this
novel approach we identified caspase-mediated proteolytic
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events that were both positively and negatively regulated by
phosphorylation. We identified and validated three proteins
from our screen; Yap1 and Golgin-160 were degraded less
when phosphorylated, whereas phosphorylation promoted
cleavage of MST3. Approximately one in three identified
caspase substrates exhibited an effect of phosphorylation on
cleavage (based on proteins for which negative effects of
phosphorylation were equal to or greater than that of Yap1 or
positive effects of phosphorylation were equal to or greater
than that of MST3). In accordance with the work of Dix et al.
(15), our data suggest that the majority of proteins for which
phosphorylation has an effect on cleavage undergo more
extensive cleavage when phosphorylated. In fact, our TAILS
analysis revealed that proteins in which phosphorylation ap-
peared to promote cleavage outnumbered proteins in which
phosphorylation prevented cleavage by more than 3-fold (15
proteins with more cleavage than MST3 in phosphorylated
lysates versus 4 proteins with less cleavage than Yap1 in
phosphorylated lysates). Overall, these data demonstrate the
potential for widespread influence of phosphorylation on
caspase cleavage.
One benefit of our experimental design was that it enabled
us to monitor the effects of phosphorylation on cleavage
irrespective of its distance from the scissile bond—an impor-
tant consideration, as there is no way to predict how phos-
phorylation sites outside the caspase motif might affect the
FIG. 5. Relative activities of caspase-3 and caspase-7 with model and phosphopeptides containing serine residues positioned within
the P5–P4 consensus motif for caspase cleavage. Caspase cleavage of peptide substrates was measured using fluorescence of an
internally quenched tryptophan residue at 355 nm after excitation at 280 nm. Peptides or phosphopeptides modeled after Golgin-160 (A) and
PARP1 (B) were assayed with caspase-3 or caspase-7 for 10 min at 37 °C and stopped by an excess of the irreversible caspase inhibitor
zVAD-fmk. Error bars represent the standard deviation of four reactions. A, means of the caspase activities toward phosphorylated peptides
and their nonphosphorylated counterparts were compared using analysis of variance and Tukey’s test. For caspase-3, P4, P3, P1, P2, P3,
and P4 phosphopeptide versus nonphosphorylated peptide pairs had p values  0.0001, whereas all other pairs had a p value  0.05. For
caspase-7, P4, P3, P2, P3, and P4 phosphopeptide versus nonphosphorylated peptide pairs had p values  0.0001, whereas all other pairs
had a p value  0.05. B, cleavage of P4 peptides, in which serine or phosphoserine was substituted for aspartic acid, was not measurable at
200 nM of caspase-3 or 600 nM of caspase-7, so caspase concentrations were increased 5-fold (*). Error bars represent the standard deviation
of four reactions. All pairs had p values  0.0001, except for the P3 pair, which had a p value  0.05.
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proteolysis of proteins. Importantly, our peptide cleavage as-
says revealed that phosphoserine within, or just proximal to,
the canonical caspase consensus motif is primarily inhibitory.
Taken together with the observation that MST3 proteolysis is
promoted by phosphorylation, this supports a model by which
substrate phosphorylation can promote caspase motif acces-
sibility or structure when occurring outside of the context of the
motif itself. One potential limitation of our approach relates to
the high stoichiometry of caspase-site phosphorylation required
in order for a difference in susceptibility to be measurable. In an
effort to overcome this limitation, we treated cells with
okadaic acid to preserve phosphosite occupancy. Similarly,
the effect of phosphorylation on cleavage is not necessarily
absolute, such as at P3, for example. To avoid complete
digestion of proteins with phosphorylation sites at these
residues, we used two different caspase concentrations.
Despite these caveats, we were able to uncover a number of
modulated caspase substrates and validated Yap1, MST3,
and Golgin-160 as caspase targets that experience altered
degradation in response to lysate dephosphorylation.
Yap1 and Golgin-160 have phosphoacceptor residues at
positions that, when occupied with phosphate, were inhibitory
toward the cleavage of peptide substrates. Although the
phosphorylation status of P4 serine on Golgin-160 and P1
threonine on Yap1 has not been confirmed in phospho-pro-
teomics studies, their occupancy would be consistent with
cleavage patterns we observed on peptide substrates and in
lysate cleavage assays. At this point, we cannot rule out that
remote phosphorylation sites may contribute to reduced sus-
ceptibility to proteolysis in a manner similar to how phosphor-
ylation at S422 on Acinus-S reduces cleavage at D355 (12).
Interestingly, Golgin-160, like other members of the Golgi
complex, is dismantled via caspase cleavage early in the
apoptotic response (36). Golgin-160 is cleaved at D59, D139,
and D311—the site we identified—with purified caspases and
in cells after treatment with diverse apoptotic stimuli (30). In
our validation studies, we inferred via differential migration of
Golgin-160 cleavage products that two sites (D59 and D139)
were cleaved in phosphorylated lysates but that proteolysis at
SEVD311 was blocked by phosphorylation. Interestingly, in
response to apoptotic signals initiating from death receptors
or endoplasmic reticulum stress, noncleavable forms of Gol-
gin-160 can actually block apoptotic progression (31), though
the effect of blocking each caspase site in isolation remains
unknown. Yap1 is another caspase target that we validated
for which phosphorylation inhibits caspase cleavage.
DEMD424 has not previously been identified as a caspase
cleavage site, but ASTD111 is cleaved in Jurkat cells in re-
sponse to apoptotic induction by TRAIL and staurosporine,
perhaps explaining why we observed multiple cleavage prod-
ucts in our validation studies (28). Furthermore, P3 and P2 of
ASTD111 have previously been identified as phosphorylated in
cells (37), perhaps clarifying results from our Western blots
that indicated multiple cleavage products were differentially
regulated between the phosphorylated and phosphatase-
treated lysates. In terms of functionality, Yap1 is a transcrip-
tional effector of the MST1 and MST2 kinases (38), which are
also targeted by caspases and function in apoptotic progres-
sion (24, 39). Interestingly, MST1 and MST2 contain previ-
ously identified phosphorylation sites at P1 and P3, suggest-
ing that caspase cleavage of multiple constituents of the
same pathway is hierarchically regulated by phosphorylation
(40). As well, MST1 phosphorylation by Akt at T387, a site
distant from the scissile bond, blocks cleavage (41), further
implicating the control of proteolytic processing of this path-
way as an important signaling event.
In the case of MST3, treating cells with the phosphatase
inhibitor calyculin A promotes phosphorylation, activation,
and structural reordering that alters its interaction partners
(42). One interpretation of our data supports a model whereby
MST3 is preferentially cleaved in its active form because our
N-terminomic strategies used lysates from cells treated with
okadaic acid, a phosphatase inhibitor that, like calyculin A,
inhibits PP1 and PP2 (42). As well, MST3 is a pro-apoptotic
kinase that exhibits increases in activity after the removal of its
C terminus by caspase cleavage (29). A function of this hy-
pothetical hierarchical layer of regulation is that phosphory-
lation and cleavage could provide graded levels of MST3
activity.
FIG. 6. Relative activity of caspase-8 with model peptides con-
taining serine or phosphoserine at each position from P4 to P3.
Peptides modeled after the caspase-8 cleavage site of pro-caspase-3
were incubated with caspase-8 (100 nM) for 5 min at 37 °C before the
reaction was terminated by an excess of the irreversible caspase
inhibitor zVAD-fmk. Error bars represent the standard deviation of
four reactions. Means of the caspase activities toward the phos-
phorylated and the corresponding nonphosphorylated peptide were
compared using analysis of variance and Tukey’s test. All pairs had
p values  0.001, except for the P3 and P3 pair, which had
p values  0.05.
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As a logical extension of the unbiased investigation of the
effect of phosphorylation on caspase-mediated degradation
in the proteome, we were also interested in systematically
evaluating the determinant properties of phosphorylated res-
idues in the context of model substrate peptides. Given the
size and charge of phosphoryl residues, we speculated that
phosphorylation might have effects outside of the canonical
P4–P1 caspase motif. Along these lines, even unmodified
amino acids have exhibited determinant properties at P6, P5,
P2, and P3, and Dix et al. (15) recently catalogued a large
number of caspase sites with phosphorylated residues in an
extended motif, though precise effects of phosphorylated
residues at many positions remain unknown (34). In system-
atically analyzing the positional effect of phosphoserine on
caspase cleavage, we found that phosphorylated residues
outside the canonical caspase motif inhibited caspase-medi-
ated cleavage. Prime side (C-terminal of the scissile bond)
determinants inhibited cleavage as far away as four residues
from the scissile bond, and the inhibitory capacity was in-
versely proportional to the distance from the catalytic machin-
ery. This finding may be partly explained by previous obser-
vations made by Stennicke et al. (33), who showed that
negative determinants at P1 fail to stabilize the transition
state, and therefore the bulky, highly charged phosphoserine
might act similarly, but with diminishing effects when dis-
tanced from the catalytic machinery. There is also evidence of
an S5 binding site (interacting with P5) on caspases in that P5
residues positively influence cleavage by caspase-3 (43) and
direct selectivity between caspase-3 and caspase-7 (34). We
investigated the effect of phosphorylation at this position,
observing inhibitory effects consistent with a preference for
small non-polar residues by caspase-3 (34). The determinant
properties of P5 on caspase-7 are less obvious, making spe-
cific reasons for phospho-P5 difficult to reconcile (34). Inter-
estingly, phosphoserine at P5 in the Golgin-160 series re-
sulted in little change in cleavage, suggesting that the effects
at this position might be context dependent.
Inhibitory effects at P4, P2, and P1 were consistent with
the literature, but we did note a discrepancy at the P3 posi-
tion. Dix et al. (15) found that phosphorylated P3 on substrate
peptides is strictly a positive factor for caspase-8 cleavage
and either promotes or has no effect on caspase-3 mediated
degradation, whereas, like Toszer et al. (8), we observed no
effect at this site for both caspase-3 and caspase-8. We
cannot definitively explain this discordance, but we can spec-
ulate that reaction conditions might have played a role. First,
Dix et al. (15) used enzyme:substrate ratios 10-fold to 100-fold
greater than our own, and reaction times that were 20 times
longer, suggesting that their enzymes were less stable. For
caspase-8, we used the chaotropic agent sodium citrate,
which promotes caspase activity by stabilizing the dimeric
form (44). Collectively, it is possible that determinant proper-
ties of phosphorylated P3 might depend on reaction condi-
tions that affect enzyme stability. Another possibility is that
the results were affected by the substrate peptides used; Dix
and colleagues (15) tended toward longer peptides and those
with sequences that differed from our model, suggesting that
lengthier peptides or pairwise primary amino acid interactions
could affect cleavage. At minimum, our mutual findings are
consistent in that phosphorylated P3 did not universally inhibit
cleavage.
In accordance with the literature, phospho-P2 and phos-
pho-P1 were also inhibitory toward proteolysis (8, 13). Of
note was the measureable activity of caspase-8 against these
peptides, whereas activity of caspase-3 and caspase-7 was
not detected under the conditions used. Furthermore, base-
line levels of cleavage by caspase-8 for peptides phosphory-
lated at P2 and P4 were also above background, perhaps
suggesting greater tolerance against inhibitory effects of
caspase-8 site phosphorylation. Along these lines, the only
known caspase-8 protein substrates negatively regulated by
phosphorylation are phosphorylated at two sites within the
cleavage motif; phosphorylation at P2 and P1 of procaspase-3
blocks its cleavage by caspase-8 (13), and phosphorylated P2
and P2 prevents cleavage of Bid (9). In this way, phosphoryl-
ation at multiple, slightly tolerated positions might function to
grade cleavage and modulate signaling output.
In summary, we used two strategies to elucidate the interplay
between caspase substrate phosphorylation and proteolysis.
We systematically characterized the primary sequence deter-
minant properties of phosphoserine within peptide sub-
strates, and we also utilized an unbiased, N-terminomic ap-
proach to monitor caspase substrates that were regulated by
phosphorylation in the context of the proteome. Overall, we
anticipate that efforts such as ours that clarify the hierarchical
regulation of caspase substrate phosphorylation and cleav-
age will improve our understanding of apoptotic signaling and
the regulatory mechanisms that control cell survival.
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